Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Investigation Evaluating Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

NCT06485206 is registered in ClinicalTrials.gov with Highridge Medical as lead sponsor.

NCT NCT06485206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06485206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Investigation Evaluating Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
Lead sponsor
Highridge Medical
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2024
Completion date
May 31, 2029
Enrollment
97 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease